Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer
      Description

      RATIONALE: Interleukin-2 may stimulate a person's white blood cells to kill kidney cancer cells. Biomed 101 may protect normal cells from the side effects of interleukin-2. PURPOSE: Phase I trial to study the effectiveness of Biomed 101 in treating patients receiving interleukin-2 for kidney cancer.

      Conditions
      Drug ExtravasationKidney Cancer
      Talk to us